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KAWASAKI SYNDROME IN TEXAS 
 
ABSTRACT 
The purpose of this study was to examine the hospitalization rates of Kawasaki Syndrome 
(KS) among children living in Texas to isolate clusters, identify demographic disparities, and 
suggest possible causative factors.  A retrospective cross-sectional study design identified 330 
KS cases from 2,818,460 hospital discharges extracted from the 2004 Texas hospital discharge 
database. Categorical variables and proportions were analyzed using Pearson Chi-Square 
analysis for bivariate comparison of hospitalization rates and other demographic and 
geographic variables.  Overall, the majority of the cases (61.5%) fell within the 1 to 4 year age 
category, representing the highest hospitalization rate at 14.3 per 100,000 children. Almost 
75% of the KS population was less than five years old with a hospitalization rate that was 
about eight times higher than all other children ( p<0.05). The KS diagnosis occurred for only 
49.4% of all KS cases upon admission. About 52% of Non Hispanic Blacks (NHB) used the 
ER as their main source of admission and Medicaid was the main payment source for 
Hispanics (67.2%). High density clusters were identified in major metropolitan areas, with the 
Dallas-Fort Worth and Houston areas representing 26.6% and 18.8% of all of the state’s 2004 
KS cases, respectively. Although the overall hospitalization rate of KS in Texas is consistent 
with national rates, significant high risk areas exist, both geographically and demographically. 
The highest hospitalization rate of KS was found among Asian and Pacific Islanders and NHB 
children which suggest genetic predisposition for the first group and reflect difficulties with 
access to healthcare for NHB. With an initial diagnosis rate of less than 50%, educating 
physicians and other healthcare providers to recognize of the symptoms of KS is imperative, 
particularly for ER and primary care providers. Support is recommended mandating KS as 
reportable condition by hospitals. 
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INTRODUCTION 
Kawasaki Syndrome (KS) is a disease that involves the skin, mouth, and lymph nodes 
typically affecting children under five years of age (American Heart Association [AHA] 2001; 
Centers for Disease Control [CDC] 2007;Kawasaki Disease Foundation 2007) . It is currently 
one of the leading causes of acquired cardiovascular disease in children in the U.S. (AHA 
2001; CDC 2007; Kawasaki Disease Foundation 2007). KS was first described in Japan by 
Kawasaki in 1967 (Kawasaki, Kosaki, Okawa, Shigematsu, and Yanagawa 1974). The first 
cases reported beyond Japan’s islands occurred in Hawaii and reported in 1976 (Melish, 
Hicks, and Larson 1976). 
We defined KS according to Centers for Disease Control (CDC 2007) and American 
Heart Association (AHA 2001) criteria. These diagnostic criteria include presence of a high 
fever for four or five days duration along with four or more additional symptoms. The 
additional clinical signs include rash, red eyes, red swollen and cracked lips, "strawberry" 
tongue, swollen hands and feet, swollen lymph nodes, or redness of the palms of the hands and 
of the soles of the feet (AHA 2001).For epidemiologic surveillance, CDC (2007) defines KS 
as a patient demonstrating fever for five or more days or until the date of administration of 
intravenous immunoglobulin, if given before day five of fever, and the presence of at least 
four of the clinical signs of rash, cervical lymphadenopathy at least 1.5 cm in diameter, 
bilateral conjunctival injection, oral mucosal changes, and peripheral extremity changes. 
When the fever is misinterpreted and the rash is overlooked by physicians, KS can 
progress untreated. Cardiac involvement of an untreated KS child can have serious and 
sometimes fatal consequences (Newburger et al. 2004). The main complication for those 
surviving KS is Coronary Artery Aneurysms (CAA); (Freeman and Shulman 2006). CAA has 
an 8.6% incidence in patients meeting the diagnostic criteria for KS and a 25% incidence in 
those not receiving a timely KS diagnosis (Freeman and Shulman 2006). 
Treatment within ten days after onset of fever is essential to decrease the risk of heart 
problems. With appropriate detection and treatment, the incidence of CAA can be reduced to 
from 1% to 5% (Gersony 1991). Treating KS consists of administering intravenous 
immunoglobulin (IVG) for 8 to 12 hours within ten days of fever onset. High doses of aspirin 
are administered until the fever subsides. A decreased dosage of aspirin continues for at least 
two months to reduce spontaneous coronary thrombosis (Rauch 1987). 
The etiology of KS is unknown. Possible causes are prior respiratory disease, exposure 
to carpet cleaning chemicals, use of humidifiers, or living in close proximity to bodies of 
water (Rauch et al. 1988; Rauch et al. 1991; Lloyd et al. 2001; Kawasaki Disease Foundation 
2007). Other researchers strongly have suggested an infectious cause (Rauch 1987; Gersony 
1991; Belay et al. 2005 ;). Several microbial agents, such as rickettsiae, propionibacterium 
acnes, klebsiella pneumoniae, ehrlichia sp, parainfluenza virus types 2 and 3, Epstein- Barr 
virus, rotavirus, and many others, have been studied in KS patients (Rauch et al. 1991; Chua 
2001; Belay et al. 2005; Dominguez et al. 2006).  Although multiple infectious agents and 
toxins have been implicated in the etiology of the disease, none have been confirmed to cause 
KS (Chang 2003; Burns 2007). With the etiology of KS unknown after 40 years of intense 
research (Kao 2005), no specific laboratory test, such as blood test or throat culture, has been 
developed to diagnose KS and atypical cases (CDC 2007). Delayed diagnosis and treatment 
have been unavoidable. Furthermore, diagnosis is complicated by KS’ symptoms and signs 
being present in other illnesses (Gersony 1991). 
Estimation of national and state incidence of KS has been difficult, because case 
reporting to the CDC has been sporadic (Kao 2005). Tracking has been left to state agencies 
(Holman et al. 2003). As is the case with any large passive surveillance system, only a fraction 
of the total cases have been reported (Rauch et al. 1991). 
Outbreaks of KS have been reported, but active reporting is only performed in 11 
states (Holman et al. 2003). Instead, studies using hospital discharge data have been used for 
KS surveillance and reporting (Chang 2003). In outbreak investigations conducted in Texas 
and North Carolina in 1984, and in Colorado in 1986, the CDC found KS patients’ homes 
tended to be less than 200 yards from the nearest body of water, usually a creek or drainage 
ditch (Rauch et al. 1988). Additionally, Chang found the overwhelming majority of children 
with KS (>96%) are hospitalized (Burns et al. 1984). In the U.S. in 2005, the estimated 
number of new KS cases totaled 5,000, and the attack rate for children under five years of age 
was 20 to 25 cases per 100, 000 children (Chang 2003). In Texas, the current incidence of KS 
and CAA resulting from KS is not known, because KS is not actively tracked by the Texas 
Department of State Health Services (Su 2007). 
Kawasaki Syndrome is most common among children of Japanese and Korean descent 
but can affect all ethnic and racial groups (Belay et al. 2006). Evidence indicates a higher rate 
of KS among Asian Americans and Pacific Islanders (32.5 cases per 100,000 children less 
than five years old). The rates are less for Non-Hispanic Blacks (16.9 cases per 100,000 
children less than five years old) and Hispanics (11.1 cases per 100,000 children less than five 
years old). The lowest rate was among Non-Hispanic Whites (9.1 cases per 100,000 children 
less than five years old (Newburger et al. 2004). For the Hispanic group, treatment for the 
CAA outcome of KS has been reported as being delayed due to the group’s lack of access to 
healthcare (Belay et al. 2006). 
The purpose of the present study was to describe the hospitalization rate of KS in 
Texas children using the Texas hospital discharge database and to describe the demographic 
characteristics of Texas children with KS. 
 
 
METHODOLOGY 
This retrospective cross-sectional study employed data from a public domain data file 
maintained by the Texas Health Information Council (THCIC), the Texas warehouse of 
hospital discharge data (Texas Department of Health Services 2004). Data were extracted 
from a base population of 2,818,460 hospital discharges obtained from the 2004 public 
THCIC dataset. Cases with KS were identified using the International Classification of 
Diseases, 9th revision Clinical Modification (ICD-9 CM) code: 446.1 for Kawasaki Syndrome 
or mucocutaneous lymph node syndrome present in the principal discharge diagnosis and all 
other discharge diagnoses (U.S. Department of Health and Human Services 1988; Texas State 
Data Center 2005). 
 
Characteristics of Interest 
Age, gender, race/ethnicity, risk mortality, illness severity, admitting diagnosis, source 
of admission, and payment source were investigated. The six age categories were, 
respectively, less than 1 year, 1 to 4 years, 5 to 9 years, 10 to 14 years, 15 to 17 years, and 18 
years or older. For specific comparisons, these categories were dichotomized into less than 
five years old and equal or greater than five years old. Race and ethnicity were restructured to 
four major groups of Non-Hispanic Whites (NHW), Non-Hispanic Blacks (NHB), Hispanics, 
and Asians and Pacific Islanders (API). Other admitting diagnosis in KS patients included: 
fever (ICD9 code 780.6), and rash (ICD9 code 782.1). All other admitting diagnoses were 
combined and placed in the category labeled as Other with their frequencies less than five 
percent. Principal diagnosis was identified in the same way in terms of ICD 9th CM. 
Admission sources included Emergency Room (ER), physician referral, transfer from other 
hospital, or other. Risk of mortality score and severity of illness was assigned from All Patient 
Refined Diagnosis Related Group (APR-DRG) from the 3M APR-DRG Grouper, version 20, 
indicating the likelihood of dying and the extent of physiologic decompensation. The four 
insurance status groups were private insurance, Medicaid, uninsured (self pay or indigent), and 
Other-labeled insurance. The Texas counties with more than four percent of the state’s KS 
admissions are reported in Table 3. 
 
Data Analysis 
Categorical variables and proportions were analyzed using Pearson Chi -Square 
analysis for bivariate comparison by ethnicity, gender, and other variables. Hospitalization 
rates (Chang 2003) were calculated with the number of cases as numerator and the population 
estimate for 2004 by age as denominator (proxy for incidence rate). The population estimate 
for 2004 by age and county were obtained from the Texas State Data Center and Office of the 
State Demographer (Texas State Data Center 2005). A p-value of less than 0.05 was 
considered statistically significant. Statistical analyses were performed using SPSS version 15. 
For this study’s protocol, appropriate approvals related to the protection of human subjects 
were sought and received from the Institutional Review Board of the University of North 
Texas Health Science Center at Fort Worth. 
RESULTS 
Patient Characteristics 
The discharge diagnosis consistent with KS was identified for a total of 330 cases. 
Sixty percent were male, 5.7 % API, 37.9% Hispanic, 31.9% NHW and 17.6% NHB. The 
stratified age distribution for the 330 KS cases is shown in Table 1. The majority of the cases 
at 61.5% fell in the 1 to 4 years of age category. This age category represented the highest 
hospitalization rate at 14.3 per 100,000 children. Almost 75% of the KS population was less 
than five years old, and its hospitalization rate was about eight  times higher than greater or 
equal than five years old (13.8 per 100,000 children versus 1.8 per 100,000 children, 
respectively), which was significant (p<0.05, Table1). For the category with age less than one 
year old, the highest hospitalization rate for API was 44.9 per 100,000, while NHW displayed 
8.8 per 100,000 children and NHB and Hispanics exhibited 14.7 and 12.5 per 100,000 
children, respectively (p< 0.05).  
As seen in Table 1 with hospitalization rates by race/ethnicity for those less than five 
years old, the highest hospitalization rate occurred for API and NHB with 29.8 and 18.4 per 
100,000 children respectively, as compared to NHW representing 9.7 per 100,000 children (p< 
0.05). In both age groups, NHB presented significantly higher hospitalization rates than NHW, 
the control group. In comparing age group by gender, males’ less than one year old category, 
were diagnosed with KS at twice as often as females of the same age and demonstrated 
significant higher hospitalization rates (p< 0.05), (Table 1). Anecdotally, only two cases of KS 
with CAA were reported. 
Table 1 about here 
 
Table 2 presents the results of risk mortality, illness severity, admitting diagnosis, 
source of admission, and payment source by ethnicity for the 330 KS cases. Regarding 
admitting diagnoses, KS was diagnosed as such only 49.4% of the time upon admission to the 
hospital and only 22.2% in the API group. Fever was the second most frequent admitting 
diagnosis at 32.4% and occurred at a 72.2% rate for the API group. Rash and non specific 
eruption were present in 5.8% of the cases and was higher for NHW (9.5%; Table 2). There 
were 41cases with all other admitting diagnoses constituting 12% of all cases. The variable, 
Physician referral was the source of admission for 48.8% of the cases followed by ER 
admission for 39.7%. Non Hispanic blacks’ use of the ER was 51.7% as compared to 33.3% 
for NHW. Non Hispanic blacks had a much lower private insurance rate (36.2 %) than NHW 
(53.3%; Table 2). Hispanics used Medicaid as their primary payment source (67.2%) more 
than three times as often as NHW (20 %).  
 
Table 2 about here 
 
Table 3 depicts the Texas counties representing at least 4% of the 2004 KS cases. 
Collin County had the highest incidence rate of KS in the Texas Counties with a rate of 29.0 
per 100,000 for children less than five years old and 30.6 per 100,000 for children of age less 
than 1 year old. Travis County presented a high hospitalization rate with 42 per 100,000 
children of age less than one year old. Harris County, which includes Houston, reported the 
most KS cases in the state; Dallas County reported the second highest number of cases. The 
two counties’ hospitalization rates were 15.7 and 16.1 per 100,000 cases, respectively, in 
children of age less than five years old. Travis County, home to Austin, and Bexar County, 
home to San Antonio, showed similar frequencies of KS cases but hospitalization rates of 17.6 
and 11.7 per 100,000 children less than five years old, respectively (Table 3). Three of the 
highest hospitalization rates by county (Collin, Dallas, and Tarrant) occurred for the Dallas 
Fort Worth Metroplex (DFW) area, representing 21.5% of the state’s 2004 KS cases. By 
including the remaining DFW counties, all of DFW represented 26.6% of the state’s 2004 KS 
cases. The counties not listed in Table 3, because their frequencies less than 4%, were 
combined and placed in the category labeled as other. Consequently, 147 KS cases in the 
other-labeled counties represented 44.6% of the state’s 2004 KS cases. 
Table 3 about here 
 
DISCUSSION 
All ethnic/racial groups were affected by KS in the study sample, with the highest 
hospitalization within API for the less than five years old group at 29.8 per 100,000 children. 
This figure is close to the 32.5 per 100,000 children reported by Newburger et al. (2004) and 
to other academic evidence indicating a higher hospitalization rate of KS among API children 
(Burns 2007; Burns et al. 1984; Chang 2003; Gersony 1991; Holman et al. 2003; Kao 
2005).We concur with the former study for all other racial/ethnic patients of age less than five 
years old, based on our finding of a higher rate of 18.4 per 100,000 children for NHB and of a 
lower rate for Hispanic and NHW of 12.6 and 9.7 per 100,000 children, respectively. We find 
this pattern to be similar to that of children of age less than one year old. However, API’s KS 
hospitalization rate was 44.9 per 100,000 children. For children of all ethnicities and races 
with age less than five years old, the estimated 2004 KS hospitalization rate was 13.8 per 
100,000 children. This estimated KS rate was consistent with KS hospitalization rates reported 
in previous studies within the US (range of 9–19 per 100,000 children); Burns 2007; CDC 
2007; Chang 2003). Male children were more likely than female children in both of the age 
categories of less than 1 year old and 1 to 4 years old to be diagnosed with KS, a finding 
which corresponds with the academic evidence (Burns et al. 1984; Gersony 1991; Chang 
2003; Holman et al. 2003; Newburger et al. 2004; Kao 2005; Burns 2007;).  
Texas has an access to care crisis that disproportionately and adversely affects 
minorities’ children (Angel, Lein and Henrici 2006). Results of this study suggest that for the 
Hispanic population, the most frequent source of admission came from physician referrals 
(45.6%) in contrast to 36.2% of NHB and 53.3% of NHW. The utilization of ERs by NHB 
was the highest among subgroups (51.7%).  On the other hand, Hispanic utilization of 
Medicaid was higher at 67.2 %, followed by NHB with 53.4% in contrast to 20% of NHW. In 
particular, our findings highlight the healthcare disparities of the NHB group, more so than 
expected. Healthcare providers, in particular primary care and ER providers, must be educated 
and enables to be highly suspicious of KS in young children, in particular in API and NHB 
children, presenting with fever and rash illnesses (Anderson, Todd and Glode 2005). 
Only 49.4% of the patients in our sample were correctly diagnosed with KS upon 
admission to a hospital. Remarkably, the API group was diagnosed in only 22.2% of the cases.  
With less than 50% of the cases being diagnosed upon admission, we remain deeply 
concerned with the data revealing 41 different admitting diagnoses other than KS. Given KS’ 
long-term health impact and relative obscurity, a pediatric infectious disease research priority 
for finding its cause and another for educating providers and the direct community must be 
developed. Identification of the causative agent(s) would be a promising step toward 
developing a diagnostic test and ultimately preventing the disease (Rowley 2006). Meanwhile, 
KS cases reported annually to the voluntary, “passive surveillance system” at the CDC 
represented only about 10% of cases diagnosed with KS in the U.S. (Belay et al. 2003). A 
national “active surveillance system” for KS will facilitate the monitoring of possible 
nationwide or regional outbreaks and trends in coronary artery abnormalities resulting from 
KS. Active surveillance may enable better quality of life and potentially increase years of life 
for KS patients. 
This is the first report of Kawasaki Syndrome in Texas since the 1984 Rauch et al. 
study. Results of this study suggest there is a higher incidence rate based on using 
hospitalization rate as a proxy than that reported by Rauch et al. for Harris County (Houston, 
Texas) with 18.8% of all cases and a hospitalization rate of 15.7 per 100,000 children (Lloyd 
et al. 2001). Rauch et al. reported 61 cases over 3 consecutive years, 1982 to 1984, recording 
an incidence rate of 9.1 per 100,000 children of less than five years old and using a case 
control study.  
It is compelling that Collin County in DFW has the highest hospitalization rate at 29.1 
per 100,000 children who are less than five years of age and at 30.6 per 100,000 children who 
are less than 1 year old. The racial makeup of Collin County in 2006 included 9.7% of API 
which might explain this observation (U.S. Census 2008). Our finding that 26.6% of all Texas 
KS cases are distributed in the cluster of counties composing DFW produces great concern. 
The current body of evidence does not explain this disproportionate incidence. 
Limitations  
  The number of KS-associated hospitalizations might have been overestimated as 
multiple KS hospitalizations for single cases were not screened. Inversely, many KS cases 
could be missing from database because the disease could have been treated on an outpatient 
basis, since not all children diagnosed with KS required hospitalization. Many KS patients 
could have seen by health care providers in urgent care, outpatient, and family care settings 
and as classical cases or incomplete or atypical KS cases (Newburger et al. 2004). Further, 
contributing to the possible underestimates of KS cases, THCIC does not collect data from 
rural hospitals with less than 100 beds. 
 
CONCLUSION 
The epidemiological trend of KS in Texas is consistent with national incidence rates. 
The high incidence of KS in Non-Hispanic Black children (second only to API) is a source of 
concern, especially since they experience disparities with significant healthcare access 
problems. No significant difference was found between Hispanic and NHW children in ER 
use for KS.   
In Texas, healthcare providers clearly do not have enough experience or training with 
KS to adequately identify and treat this disease. The disease appears more frequently in Texas’ 
DFW counties. The disease is not monitored by reporting agencies in Texas. No statewide 
database is maintained, and an accurate numbers of KS cases are not collected annually by any 
agency. Support must be established to mandate KS as reportable condition by hospitals. 
Subsequently, such a mandate will establish a statewide, if not national, database for a disease 
that clearly has significant public health ramifications.  With the misdiagnosis rate more than 
50%, educating physicians and other healthcare providers to recognize of the symptoms of KS 
is imperative, particularly for ER and primary care providers.  
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Table 1: Kawasaki Syndrome Associated Hospitalization Rates by Age, 
Gender and Race/Ethnicity in Texas, 2004 
Total Age group N=330 % 
Hospitalization 
rate* 
Texas 
Population 
by age 
groups 
        
Years of age <1 year 44 13.3 11.7 375385 
   1-4 year 203 61.5 14.3 1417965 
   5-9 year 62 18.8 3.8 1620238 
  10-14 year 11 3.3 0.6 1730425 
  15-17 year 4 1.2 0.4 1028611 
       
 < 5 year 247 74.8 13.8** 914552 
 >5 year 83 25.2 1.8 878798 
      
Gender males 198 60   
  females 132 40   
Children <1 
year by race/ 
ethnicity      
 
        
  Hispanics 23 52.3 12.5 183899 
  NHW 7 15.9 8.8 136545 
  NHB 6 13.6 14.7** 40847 
  API 5 11.4 44.9** 
 
11139 
children <5 
year by race/ 
ethnicity      
 
        
  Hispanics 107 43.3 12.6 847501 
  NHW 66 26.7 9.7 680207 
  NHB 37 15 18.4** 201470 
  API  16 6.5 29.8** 53731 
Age group by 
gender      
 
  Male     
  <1  29 65.9 15.1** 191467 
   1-4 117 57.6 16.2 723085 
        
Age group by 
gender      
 
  Female     
  <1  14 34.1 8.2 183918 
  1-4 86 42.4 12.4 694880 
* Per 100,000 children * * p<0.05. NHW= Non-Hispanic Whites; NHB= Non-
Hispanic Blacks; API= Asians and Pacific Islander 
Source: Texas Health Care Information Collection (THCIC) and Texas State Data                                                                                                                                                                                                                                   
Center for 2004. 
 
Table 2: Risk Mortality, Illness Severity, Admitting Diagnosis, Source of Admission and 
Payment Source by Race/Ethnicity in Texas, 2004 
 
     
 
 
Total N  
(% based on 
330) 
 
 
NHB                   
(% based on 
58) 
Hispanics              
(% based on 
125) 
NHW              
(% based on 
105) 
API            
(% based 
on 18) 
    N   % N     % N   % N   % N   % 
Risk Mortality Minor 311 (94.2) 51 (87.9) 120 (96.0) 100 (95.2) 17 (94.4) 
  Moderate 13 (3.9) 4 (6.9) 3 (2.4) 4 (3.8) 1 (5.6) 
  Major/ Extreme 6 (1.8) 3 (5.2) 2 (1.6) 1 (1.0) 0 (0) 
Illness Severity        
  Minor 240 (72.7) 36 (62.1) 90 (72.0) 80 (76.2) 16 (88.9) 
  Moderate 72 (21.8) 16 (27.6) 30 (24.0) 19 (18.1) 1(5.6) 
  Major/ Extreme 18 (5.5) 6(10.3) 5 (4.0) 6 (5.7) 1 (5.6) 
         
Admitting 
Diagnosis 
Kawasaki 
Syndrome 
163 (49.4) 34 (58.6) 63 (50.4) 54 (51.4) 4 (22.2) 
  Fever 107 (32.4) 15 (25.9) 36 (28.8) 33 (31.4) 13 (72.2) 
  Rash/Nonspecific 
Skin Eruption   
19 (5.8) 1(1.7) 6 (4.8) 10 (9.5) 1 (5.6) 
  Other diagnosis 41 (12.4) 8 (13.8) 20 (16.0) 8 (7.7) 0 (0) 
         
Source of 
Admission 
Physician 
Referral  
161 (48.8) 21 (36.2) 57 (45.6) 56 (53.3) 10 (55.6) 
  ER  131 (39.7) 30 (51.7) 52 (41.6) 35 (33.3) 8 (44.4) 
  Transfer from 
Hospital  
25 (7.6) 4 (6.9) 10 (8.0) 11 (10.5) 0 (0) 
  Other  13 (3.9) 3 (5.2) 6 (4.8) 3 (2.9) 0(0) 
         
Payment Source Private 155 (47.0) 21 (36.2) 35 (28.0) 76 (72.4) 9 (50) 
  Medicaid 149 (45.2) 31 (53.4) 84 (67.2) 21 (20.0) 5 (27.8) 
  Self-pay/Indigent 19 (5.8) 4 (6.9) 4 (3.2) 5 (4.8) 4 (22.2) 
  Other  7 (2.1) 2 (3.4) 2 (1.6) 3 (2.9) 0 (0) 
NHW= Non-Hispanic Whites; NHB= Non-Hispanic Blacks; API= Asians and Pacific Islander 
 
Source: Texas Health Care Information Collection (THCIC) for 2004.  
Note: “Private” included any patient who had insurance whether HMO, PPO, CHAMPUS, Blue 
Cross/Blue Shield, or Commercial Insurance. 
 
 
Table 3: Texas Counties with More Than 4% of Kawasaki Syndrome Cases in 2004 
* As there was no new born with KS in Bexar in 2004 
 
 
 
County  Total 
Cases 
% Population 
<18 Years 
Hospitalization 
rate 
Per 100,000 
<18 Years 
Population 
<5 Years 
Hospitalization 
rate 
Per 100,000 
<5 Years 
Population 
<1 Year 
Hospitalization 
rate 
Per 100,000 
<1 Year 
Collin 17 5.2 177719 13.1 48176 29.0 9807 30.6 
Hidalgo 19 6.1 227814 12.2 72314 18 15977 6.3 
Travis 13 4.2 206848 9.4 68233 17.6 14287 42.0 
Harris 61 18.8 1028371 8.5 312370 15.7 66148 10.6 
Dallas 36 11.5 640376 8.2 199154 16.1 41548 12.0 
Bexar 16 4.8 410504 5.5 120029 11.7 24970 0* 
Tarrant 16 4.8 444525 5.1 130774 7.7 27172 14.7 
